Last edition
News about "Biopharmaceutical partnership"
Bristol Myers Squibb and Hengrui Pharma collaborated to jointly develop 13 early-stage programmes across oncology, haematology and immunology, with a potential deal value of up to USD 15.2 billion.
Biopharmaceutical Partnership | 13/05/2026 | By News Bureau
Evotec SE and Almirall S.A. Advance Dermatology Drug Candidate to Preclinical Stage
The Evotec–Almirall collaboration showcases the power of AI-driven drug discovery, rapidly advancing a promising dermatology candidate toward clinical development for unmet medical needs.
Biopharmaceutical Partnership | 05/05/2026 | By News Bureau
IASO Biotechnology Partners with Instituto Butantan to Localise CAR-T Therapy in Brazil
IASO Bio licenses CAR-T technology to Instituto Butantan for local development in Brazil, aiming to reduce treatment costs and expand public access to advanced therapies for haematological cancer patients.
Biopharmaceutical Partnership | 13/04/2026 | By News Bureau | 123
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy